Cantabio Pharmaceuticals Inc.
CIK 0001550518
Revenue (TTM)
$0
Q3 Jun 2019
Net Income (TTM)
−$1.16M
−80.9% YoY
Q3 Jun 2019
EPS Diluted (TTM)
—
Q3 Jun 2019
Gross Margin
—
Q3 Jun 2019
Operating Margin
—
Q3 Jun 2019
Net Margin
—
Q3 Jun 2019
Free Cash Flow (TTM)
—
Q3 Jun 2019
Cash
$283.37K
Q3 Jun 2019
Total Debt
—
Q3 Jun 2019
Shares Outstanding
112.72M sh
Q3 Jun 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.